Wednesday, June 10, 2026
🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,492

Quick answer

1,492 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7566732

    Rhodanine compositions for use as antiviral agents

    Rigel Pharmaceuticals, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7566719

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7566465

    Artemisinins in the clinical and veterinary management of kinetoplastid infections

    The United States of America as represented by the Secretary of the Army · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7553490

    Vaccines against Escherichia coli O157 infection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7537765

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7534613

    Methods of treating parkinson's disease using viral vectors

    The Regents of the University of California · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7528274

    Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7521418

    Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent

    Theravance, Inc. · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7514410

    Hepatitis C therapies

    BioCryst Pharmaceuticals, Inc. · Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7511124

    Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7501494

    Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection

    United Biomedical, Inc. · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7498353

    Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7494988

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Tue Feb 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7479484

    Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7470430

    Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7455833

    Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7452861

    Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

    Theravance, Inc. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7452544

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7432047

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7429485

    Method of producing infectious reovirus

    ONCOLYTICS BIOTECH INC. · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7425611

    Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7417136

    Nucleic acid vaccines for prevention of flavivirus infection

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7410979

    Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7393855

    2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and pyrimidines as antiviral agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7390646

    Bacterial vectors and methods of use thereof

    The Regents of the University of California · Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7388017

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7388002

    Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

    BioCryst Pharmaceuticals, Inc. · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7384909

    Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7378257

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7378386

    Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives

    The Board of Regents of the University of Texas System · Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7374872

    CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7371372

    Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection

    Vertex Pharmaceuticals Incorporated · Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7368452

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7354900

    Treatment and inhibition of ocular infections and wounds by CAP37 and CAP37 peptides

    The Board of Regents of the University of Oklahoma · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7348314

    Compositions and methods for inhibiting viral replication

    Alnylam Europe AG · Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7344703

    Mycobacterial sulfation pathway proteins and methods of use thereof

    The Regents of the University of California · Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7332321

    Viral fibers

    The Board of Regents of the University of Texas System · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7332602

    Pyridyl substituted heterocycles useful for treating or preventing HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7326542

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7326695

    Anti-bacterial agents based upon oxoanion binding

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7323340

    Compositions and methods for regulating bacterial pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7319000

    Compositions and methods for eliciting immune or anti-infective responses

    The Board of Regents of the University of Texas System · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7319091

    Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7314858

    Retrocyclins: antiviral and antimicrobial peptides

    The Regents of the University of California · Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7311916

    Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7306914

    Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy

    Odyssey Thera Inc. · Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7306804

    HIV-specific T-cell induction

    The Board of Regents of the University of Texas System · Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7304127

    Polypeptides that bind HIV gp120 and related nucleic acids, antibodies, compositions, and methods of use

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Infectious disease patents are indexed?

1,492 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.